Cognetivity Neurosciences Ltd. (CGNSF)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Dec 30, 2025
Cognetivity Neurosciences Revenue
Cognetivity Neurosciences had revenue of 29.16K CAD in the quarter ending October 31, 2023. This brings the company's revenue in the last twelve months to 98.97K. In the fiscal year ending January 31, 2023, Cognetivity Neurosciences had annual revenue of 45.37K.
Revenue (ttm)
98.97K CAD
Revenue Growth
n/a
P/S Ratio
0.00
Revenue / Employee
n/a
Employees
n/a
Market Cap
94.00 USD
Revenue Chart
* This company reports financials in CAD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jan 31, 2023 | 45.37K | - | - |
| Jan 31, 2022 | - | - | - |
| Jan 31, 2021 | - | - | - |
| Jan 31, 2020 | - | - | - |
| Jan 31, 2019 | - | - | - |
| Jan 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Babylon Holdings | 1.15B |
| ETAO International | 58.89M |
| Cue Health | 56.23M |
| Aspyra | 7.75M |
| Alternate Health | 3.34M |
| Patient Access Solutions | 1.82M |
| Natural Health Farm Holdings | 1.17M |
| Frélii | 81.96K |